Antabio's Series A - II Round

Antabio raised a round of funding on July 12, 2018.

Antabio is a biopharmaceutical company developing novel antibacterial resistance-breakers to treat drug-resistant infections in areas of highest unmet medical need.…

Articles about Antabio's Series A - II Round: